Differential Modulation by Delta9-Tetrahydrocannabinol (∆9-THC) of CD40 Ligand (CD40L) Expression in Activated Mouse Splenic CD4+ T cells

Receptors and Channels Targeted by Synthetic Cannabinoid Receptor Agonists and Antagonists

(2010) R. Pertwee   CURRENT MEDICINAL CHEMISTRY

The role of the glucocorticoid receptor in inflammation and immunity

(2010) Ulrike Baschant et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Post-transcriptional regulation in Lymphocytes: The case of CD154

(2010) Stefano Vavassori et al.   RNA Biology

In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells

(2009) Stefano Vavassori et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Molecular mechanism and function of CD40/CD40L engagement in the immune system

(2009) Raul Elgueta et al.   IMMUNOLOGICAL REVIEWS

Cannabinoid Receptor Type 1- and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling

(2009) Christine Börner et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Nuclear factor of activated T cells (NFAT) mediates CD154 expression in megakaryocytes

(2008) S. A. Crist et al.   BLOOD

Suppression of T cell costimulator ICOS by  9-tetrahydrocannabinol

(2008) H. Lu et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Δ9 -tetrahydrocannabinol

(2008) Alison E. B. Springs et al.   JOURNAL OF LEUKOCYTE BIOLOGY

CB1 and CB2 Cannabinoid Receptors Mediate Different Aspects of Delta-9-Tetrahydrocannabinol (THC)-Induced T Helper Cell Shift Following Immune Activation by Legionella Pneumophila Infection

(2008) Catherine A. Newton et al.   Journal of Neuroimmune Pharmacology

CD40–CD40 ligand interactions in oxidative stress, inflammation and vascular disease

(2008) Muhammad Rizvi et al.   TRENDS IN MOLECULAR MEDICINE

Novel cannabinoid receptors

(2007) A J Brown   BRITISH JOURNAL OF PHARMACOLOGY